Cargando…

PNSA, a Novel C-Terminal Inhibitor of HSP90, Reverses Epithelial–Mesenchymal Transition and Suppresses Metastasis of Breast Cancer Cells In Vitro

Metastasis accounts for the vast majority of deaths in breast cancer, and novel and effective treatments to inhibit cancer metastasis remain urgently developed. The expression level of heat shock protein 90 (HSP90) in invasive breast cancer tissue is higher than in adjacent non-cancerous tissue. In...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Aotong, Qi, Xin, Du, Fu, Zhang, Guojian, Li, Dehai, Li, Jing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923764/ https://www.ncbi.nlm.nih.gov/pubmed/33672529 http://dx.doi.org/10.3390/md19020117

Ejemplares similares

HSP90AA1 promotes lymphatic metastasis of hypopharyngeal squamous cell carcinoma by regulating epithelial-mesenchymal transition
por: TANG, FENGXIANG, et al.
Publicado: (2023)

Doxycycline reverses epithelial-to-mesenchymal transition and suppresses the proliferation and metastasis of lung cancer cells
por: Qin, Yuan, et al.
Publicado: (2015)

Activation of STING by cGAMP Regulates MDSCs to Suppress Tumor Metastasis via Reversing Epithelial-Mesenchymal Transition
por: Cheng, Hao, et al.
Publicado: (2020)

Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial–mesenchymal transition (EMT) to mesenchymal–epithelial transition (MET) states
por: Yoshida, T, et al.
Publicado: (2014)

GW4869 Can Inhibit Epithelial-Mesenchymal Transition and Extracellular HSP90α in Gefitinib-Sensitive NSCLC Cells
por: Wan, Xuan, et al.
Publicado: (2023)

Extracellular HSP70/HSP70-PCs Promote Epithelial-Mesenchymal Transition of Hepatocarcinoma Cells
por: Li, Hangyu, et al.
Publicado: (2013)

Isoliquiritigenin Inhibits Ovarian Cancer Metastasis by Reversing Epithelial-to-Mesenchymal Transition
por: Chen, Chen, et al.
Publicado: (2019)

Upregulation of FBXW7 Suppresses Renal Cancer Metastasis and Epithelial Mesenchymal Transition
por: Cai, Yangke, et al.
Publicado: (2017)

The Therapeutic Roles of Recombinant Hsp90α on Cornea Epithelial Injury
por: Wang, Mingli, et al.
Publicado: (2022)

RYBP Inhibits Progression and Metastasis of Lung Cancer by Suppressing EGFR Signaling and Epithelial-Mesenchymal Transition()()
por: Dinglin, Xiaoxiao, et al.
Publicado: (2017)

miR-10a suppresses colorectal cancer metastasis by modulating the epithelial-to-mesenchymal transition and anoikis
por: Liu, Yankun, et al.
Publicado: (2017)

Sinomenine Hydrochloride Inhibits the Metastasis of Human Glioblastoma Cells by Suppressing the Expression of Matrix Metalloproteinase-2/-9 and Reversing the Endogenous and Exogenous Epithelial-Mesenchymal Transition
por: Jiang, Yumao, et al.
Publicado: (2018)

IGFBP-rP1 suppresses epithelial–mesenchymal transition and metastasis in colorectal cancer
por: Zhu, S, et al.
Publicado: (2015)

SUV39H1 is a New Client Protein of Hsp90 Degradated by Chaetocin as a Novel C-Terminal Inhibitor of Hsp90
por: Lian, Bin, et al.
Publicado: (2021)

Luteolin suppresses gastric cancer progression by reversing epithelial-mesenchymal transition via suppression of the Notch signaling pathway
por: Zang, Ming-de, et al.
Publicado: (2017)

Epithelial–mesenchymal transition in tumor metastasis
por: Yeung, Kay T., et al.
Publicado: (2016)

Hsp90 N- and C-terminal double inhibition synergistically suppresses Bcr-Abl-positive human leukemia cells
por: Chen, Chun, et al.
Publicado: (2016)

MiR‐577 suppresses epithelial‐mesenchymal transition and metastasis of breast cancer by targeting Rab25
por: Yin, Chonggao, et al.
Publicado: (2018)

MiR-195 suppresses the metastasis and epithelial–mesenchymal transition of hepatocellular carcinoma by inhibiting YAP
por: Yu, Shuo, et al.
Publicado: (2017)

Endothelial-mesenchymal transition harnesses HSP90α-secreting M2-macrophages to exacerbate pancreatic ductal adenocarcinoma
por: Fan, Chi-Shuan, et al.
Publicado: (2019)

Aqueous Huaier Extract Suppresses Gastric Cancer Metastasis and Epithelial to Mesenchymal Transition by Targeting Twist
por: Xu, Zhiyuan, et al.
Publicado: (2017)

Epithelial-to-mesenchymal transition markers to predict response of Berberine in suppressing lung cancer invasion and metastasis
por: Qi, Hui-wei, et al.
Publicado: (2014)

TP53I11 suppresses epithelial-mesenchymal transition and metastasis of breast cancer cells
por: Xiao, Tongqian, et al.
Publicado: (2019)

Restoration of PPP2CA expression reverses epithelial-to-mesenchymal transition and suppresses prostate tumour growth and metastasis in an orthotopic mouse model
por: Bhardwaj, A, et al.
Publicado: (2014)

Knockdown of CD44 inhibits the invasion and metastasis of hepatocellular carcinoma both in vitro and in vivo by reversing epithelial-mesenchymal transition
por: Gao, Yuan, et al.
Publicado: (2015)

FOXO1 inhibits the invasion and metastasis of hepatocellular carcinoma by reversing ZEB2-induced epithelial-mesenchymal transition
por: Dong, Tianxiu, et al.
Publicado: (2016)

Paxillin knockdown suppresses metastasis and epithelial-mesenchymal transition in colorectal cancer via the ERK signalling pathway
por: Wen, Long, et al.
Publicado: (2020)

HSP90 Interacts with the Fibronectin N-terminal Domains and Increases Matrix Formation
por: Chakraborty, Abir, et al.
Publicado: (2020)

A Dynamic View of ATP-coupled Functioning Cycle of Hsp90 N-terminal Domain
por: Zhang, Huaqun, et al.
Publicado: (2015)

MicroRNA-300 suppresses metastasis of oral squamous cell carcinoma by inhibiting epithelial-to-mesenchymal transition
por: Kang, Yuanyuan, et al.
Publicado: (2018)

Targeting Plasmodium falciparum Hsp90: Towards Reversing Antimalarial Resistance
por: Shahinas, Dea, et al.
Publicado: (2013)

Quercetin inhibits epithelial–mesenchymal transition, decreases invasiveness and metastasis, and reverses IL-6 induced epithelial–mesenchymal transition, expression of MMP by inhibiting STAT3 signaling in pancreatic cancer cells
por: Yu, Dinglai, et al.
Publicado: (2017)

SCAND1 Reverses Epithelial-to-Mesenchymal Transition (EMT) and Suppresses Prostate Cancer Growth and Migration
por: Eguchi, Takanori, et al.
Publicado: (2022)

Corepressor metastasis-associated protein 3 modulates epithelial-to-mesenchymal transition and metastasis
por: Du, Liang, et al.
Publicado: (2017)

PKM2 Promotes Breast Cancer Progression by Regulating Epithelial Mesenchymal Transition
por: Xiao, Hui, et al.
Publicado: (2020)

AP-2β inhibits hepatocellular carcinoma invasion and metastasis through Slug and Snail to suppress epithelial-mesenchymal transition
por: Yang, Liu, et al.
Publicado: (2018)

Regorafenib inhibits epithelial-mesenchymal transition and suppresses cholangiocarcinoma metastasis via YAP1-AREG axis
por: Chang, Yu-Chan, et al.
Publicado: (2022)

HSP90 N‐terminal inhibitors target oncoprotein MORC2 for autophagic degradation and suppress MORC2‐driven breast cancer progression
por: Yang, Fan, et al.
Publicado: (2022)

The Distinct Assignments for Hsp90α and Hsp90β: More Than Skin Deep
por: Chang, Cheng, et al.
Publicado: (2023)

Hsp90 C-Terminal Inhibitors Exhibit Antimigratory Activity by Disrupting the Hsp90α/Aha1 Complex in PC3-MM2 Cells
por: Ghosh, Suman, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_m72t62astrcja5oclld0uo4lpq